stella
beta
Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation — Stella
Recruiting
Back to Acute Bilineal Leukemia trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
M D Anderson Cancer Center, Houston, Texas
View full record on ClinicalTrials.gov